Silicone Oil From Syringes —A Potentially Overlooked Issue for Intravitreal Injections

To the Editor The study conducted by Bijon et al addresses a potentially important and underestimated issue pertaining to intravitreal injections (IVIs). Given the substantial number of IVI procedures performed globally, even seemingly minor concerns might merit attention. For instance, the 2018 American Society of Retina Specialists Preferences and Trends survey revealed that 60% of US retina specialists had encountered at least 1 patient with silicone oil (SO) droplets following IVI of bevacizumab, 5% had resorted to vitrectomy to manage symptomatic floaters secondary to SO, and 2% had witnessed patients pursuing legal action due to SO-related floaters. A recent publication has supported a much higher prevalence of SO in the vitreous than previously believed, affecting up to 80% of eyes undergoing routine IVI.
Source: JAMA Ophthalmology - Category: Opthalmology Source Type: research